CVS Health Stock-Based Compensation 2010-2024 | CVS
CVS Health annual/quarterly stock-based compensation history and growth rate from 2010 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
- CVS Health stock-based compensation for the quarter ending September 30, 2024 was $0.403B, a 12.58% decline year-over-year.
- CVS Health stock-based compensation for the twelve months ending September 30, 2024 was $1.398B, a 6.07% increase year-over-year.
- CVS Health annual stock-based compensation for 2023 was $0.588B, a 31.54% increase from 2022.
- CVS Health annual stock-based compensation for 2022 was $0.447B, a 7.64% decline from 2021.
- CVS Health annual stock-based compensation for 2021 was $0.484B, a 21% increase from 2020.
CVS Health Annual Stock-Based Compensation
(Millions of US $) |
| 2023 |
$588 |
| 2022 |
$447 |
| 2021 |
$484 |
| 2020 |
$400 |
| 2019 |
$453 |
| 2018 |
$280 |
| 2017 |
$234 |
| 2016 |
$222 |
| 2015 |
$230 |
| 2014 |
$165 |
| 2013 |
$141 |
| 2012 |
$132 |
| 2011 |
$135 |
| 2010 |
$150 |
| 2009 |
$165 |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$55.823B |
$357.776B |
|
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
|
